Company profile: N-SIDE
1.1 - Company Overview
Company description
- Provider of deeptech software and algorithms for life sciences and energy to improve decisions and optimize critical resources. Combines industry expertise with applied mathematics and AI. Products include Lighthouse, software for managing clinical trial supply chains to reduce waste, and a Power Matching Algorithm that optimizes supply and demand to determine day-ahead electricity prices.
Products and services
- Applied Mathematics & AI Software: Delivers AI-driven software transforming uncertainty, empowering life sciences and energy organizations to optimize critical resources and make better decisions
- Lighthouse: Engineers industrial-grade software for managing clinical trial supply chains, aiming to optimize resources and reduce waste in clinical trials
- Power Matching Algorithm: Architects market-scale algorithm to determine day-ahead electricity prices by optimizing supply and demand in energy markets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to N-SIDE
H1
HQ: United States
Website
- Description: Provider of a health data platform supporting end-to-end therapeutic development for medical companies and healthcare systems. Offerings include Trial Landscape for principal investigator pools, site performance and patient diversity insights; GenosAI for querying trial data; HCP Universe to discover and engage HCPs; Precise doctor directory data; and H1 Connect for global humanitarian missions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full H1 company profile →
Lindy Biosciences
HQ: United States
Website
- Description: Provider of protein therapeutic formulation technologies, including Microglassification™ to create solid amorphous microbeads for stable long-term storage and subcutaneous delivery; high-concentration biologic formulations that reduce viscosity and increase stability for subcutaneous dosing of monoclonal antibodies; and MG Suspensions offering a subcutaneous alternative to intravenous infusions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lindy Biosciences company profile →
MDC Partners
HQ: Belgium
Website
- Description: Provider of business intelligence solutions for clinical trial optimization, medical expert identification and competitive intelligence, leveraging data mining, semantic processing and engineering to deliver event-based tools to monitor and analyze.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MDC Partners company profile →
Consensus
HQ: United States
Website
- Description: Provider of an AI-powered search engine that finds answers in scientific research, enabling discovery and consumption of the world's expert knowledge.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Consensus company profile →
Presa Solutions
HQ: United States
Website
- Description: Provider of design, implementation, and management of supply chain solutions for pharmaceutical manufacturers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Presa Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for N-SIDE
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to N-SIDE
2.2 - Growth funds investing in similar companies to N-SIDE
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for N-SIDE
4.2 - Public trading comparable groups for N-SIDE
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →